Track market-moving stories before they get noisy

Image: Shutterstock

Read MoreHide Full Article

Key Takeaways GlobalFoundries will build one new plant, with a second possible, under a U.S.-Japan investment initiative.Each facility could add 900,000 wafers in annual capacity, with operations at the 1st plant expected in 2029.GFS will invest $955 million in silicon photonics, silicon-germanium and advanced packaging.
GLOBALFOUNDRIES Inc. (GFS - Free Report) has been selected to operate two new semiconductor manufacturing facilities at its Malta, New York, campus under a U.S.-Japan investment initiative worth up to $21 billion. The expansion will increase the company’s U.S. production capacity and support demand for chips used in automotive, industrial, communications and data center applications.

Under the project, GlobalFoundries will use Japan’s initial investment of around $10 billion to build a new semiconductor manufacturing plant, which is expected to begin operations in 2029. An additional investment of approximately $10 billion could fund a second facility. Each plant is expected to add around 900,000 300mm wafers of annual production capacity. The project is expected to create approximately 27,000 construction and related jobs, along with more than 1,000 skilled manufacturing positions.

Separately, the company will reallocate $955 million from its existing U.S. government award to invest in silicon photonics, silicon-germanium and advanced packaging at its New York and Vermont facilities. These technologies are expected to support growing demand for artificial intelligence (AI), cloud data centers and high-speed communications.

The investment could strengthen GlobalFoundries’ position in the U.S. semiconductor market, support key customers such as Renesas, Apple, Cirrus Logic and General Motors, and enhance its role in the global semiconductor supply chain.

GlobalFoundries’ PeersUnited Microelectronics Corporation (UMC - Free Report) provides semiconductor foundry services for chips used in communications, automotive, consumer electronics and industrial applications. The company specializes in mature and specialty process technologies, including solutions for display drivers, power management and connectivity. UMC focuses on manufacturing reliability, process efficiency and long-term customer relationships to support demand for chips across a wide range of electronic devices.

Taiwan Semiconductor Manufacturing Company Limited (TSM - Free Report) manufactures advanced semiconductors for leading global technology companies, supporting applications such as AI, high-performance computing and mobile devices. Its advanced process technologies help produce powerful, energy-efficient chips for smartphones, AI accelerators and high-performance computing systems. TSMC provides advanced packaging technologies that help improve chip performance and meet the growing computing demands of next-generation applications.

Marvell Technology, Inc. (MRVL - Free Report) develops semiconductor solutions for data infrastructure, including AI systems, cloud computing and data centers. Its portfolio includes networking chips, optical connectivity solutions and custom silicon designed to support high-speed data transfer and efficient computing. As AI workloads increase the need for faster connectivity and greater data processing capacity, Marvell is focusing on technologies that help cloud providers and enterprise customers build scalable, high-performance infrastructure.

Published in artificial-intelligence semiconductor tech-stocks

Key Takeaways DXCM's G7 shows strong results in the CONNECT trial, supports CGM use in non-insulin-treated Type 2 diabetes.DXCM's G7 users achieve a 1.6% A1C reduction and spend five additional hours daily within the target range.Dexcom's CONNECT study shows 97% CGM use at 26 weeks, strengthening evidence for broader adoption.
DexCom, Inc. (DXCM - Free Report) recently announced that results from its CONNECT randomized controlled trial have been published in The New England Journal of Medicine. The study evaluated the benefits of its Dexcom G7 continuous glucose monitoring (CGM) system in adults with Type 2 diabetes who are not using insulin, adding to the clinical evidence supporting broader CGM adoption.

The findings are encouraging for DexCom, as stronger clinical evidence could help expand CGM adoption among people with Type 2 diabetes who are not on insulin. Wider physician acceptance and improved insurance coverage could create additional growth opportunities for the company. However, the extent to which the study translates into higher sales will depend on physician adoption, reimbursement support and patient uptake.

More on the NewsThe CONNECT study screened 440 participants across 22 primary care sites in the United States, with 283 eligible adults randomized to receive either Dexcom G7 or routine care over 26 weeks. Participants using the CGM system achieved an average A1C reduction of 1.6% from a baseline of 8.8%, representing a 0.9-percentage-point greater reduction than routine care. At 26 weeks, 68% of Dexcom G7 users achieved an A1C below 7.5%, while 46% reached below 7.0%.

The group also spent approximately five additional hours per day within the target glucose range of 70-180 mg/dL, with improvements emerging within the first week of use. Benefits were observed across several demographic and clinical characteristics, including age, diabetes duration and glucose-lowering treatments. Among participants using GLP-1 therapies, DexCom G7 delivered an additional 0.9-percentage-point A1C reduction compared with routine care. Notably, 97% of participants were still using CGM after 26 weeks, with most using it daily. The findings were first presented at the American Diabetes Association's 2026 Scientific Sessions and strengthen the clinical evidence supporting CGM use among adults with Type 2 diabetes who are not using insulin.

The publication is particularly relevant because it provides evidence supporting earlier CGM use in Type 2 diabetes management, potentially expanding the addressable market beyond patients who require insulin. The study's results may encourage more physicians to recommend continuous glucose monitoring and strengthen discussions around reimbursement and broader patient access. However, translating these findings into sustained revenue growth will depend on adoption rates, payer coverage and affordability. The study also adds to the clinical evidence supporting Dexcom's G7 platform, although longer-term data will be important in assessing the durability of the observed benefits.

Recent Development by DXCMRecently, DXCM released its 2026 “State of Type 2 Report: Global Access and Attitudes to Diabetes Technology” ahead of the 62nd Annual Meeting of the European Association for the Study of Diabetes. The report highlights significant gaps in CGM awareness and access while pointing to growing potential for combining CGM with GLP-1 therapies. Dexcom also partnered with Team Novo Nordisk, an all-diabetic professional cycling team primarily sponsored by Novo Nordisk, underscoring its focus on expanding CGM awareness and adoption.

DXCM’s Industry ProspectsAccording to Grand View Research, the global CGM devices market size was valued at $13.4 billion in 2025 and is projected to grow beyond $41.4 billion by 2033, at a CAGR of 15.1% from 2026 to 2033.

The primary driver of market growth is the rising global prevalence of diabetes, which has increased demand for more efficient, real-time glucose monitoring solutions.

Updates From DXCM PeersAbbott Laboratories (ABT - Free Report) recently reported new real-world evidence supporting the benefits of CGM technology, including its FreeStyle Libre systems, for adults with Type 2 diabetes using basal insulin. According to studies, CGM use was associated with a 45% lower risk of death at 12 months and a 36% lower risk at 24 months.

A separate French observational study involving more than 253,000 people with Type 2 diabetes found that Abbott's Libre technology was associated with lower hospitalization rates for acute diabetes-related events across different treatment groups. These findings strengthen the clinical evidence supporting CGM adoption and could help ABT expand the reach of its diabetes care portfolio.

Medtronic (MDT - Free Report) recently completed the exchange-offer process for its diabetes business, MiniMed Group and announced final results on Oct. 14, 2026. The offer was oversubscribed, and Medtronic exchanged its remaining 252.8 million MiniMed shares for approximately 55 million Medtronic ordinary shares. Following the transaction, Medtronic will no longer retain an ownership stake in MiniMed, which is expected to operate as an independent publicly traded company.

The separation marks a strategic shift for Medtronic, allowing it to focus more closely on its remaining medical technology businesses, while MiniMed will pursue growth in diabetes care as a standalone company. The development is relevant to the competitive landscape for diabetes devices, although its longer-term impact will depend on MiniMed's performance as an independent business.

Insulet (PODD - Free Report) announced enhancements to its Omnipod 5 automated insulin delivery system in June 2026, alongside expanded compatibility with Abbott's FreeStyle Libre 3 Plus sensor in the United States. The upgraded algorithm introduces a 100 mg/dL target glucose setting and improved alarm handling, aiming to improve time in range and help users spend more time in automated mode. The expanded sensor compatibility also gives users greater flexibility in choosing their diabetes management technology. Separately, Insulet reported second-quarter 2026 revenues of $801.7 million, up 23.5% year over year, with Omnipod revenue increasing 24.6%.

These developments highlight continued product innovation and commercial momentum, which could support Insulet's growth in automated insulin delivery. However, sustained performance will depend on continued adoption, international expansion and execution in an increasingly competitive diabetes technology market.

Key Takeaways Amkor's Computing revenues hit a Q2 record, rising 20% sequentially and 23% year over year on AI demand.Amkor targets four 2.5D and four HDFO product launches in 2026, alongside TSMC and NVIDIA partnerships.Amkor's gross margin rose to 16.8%, but $2.5B-$3B in 2026 capex and Arizona ramp risks may pressure margins.
Amkor Technology (AMKR - Free Report) is benefiting from accelerating AI and data center investments, driving demand for its advanced semiconductor packaging and test solutions. Computing revenues reached a quarterly record in the second quarter of 2026, increasing 20% sequentially and 23% year over year. Management projected nearly 30% sequential Computing revenue growth in the third quarter, supported by AI infrastructure demand and its high-density fan-out (HDFO) data center CPU ramp.

The opportunity extends beyond one program. Amkor has active engagements across 2.5D integration, HDFO and emerging co-packaged optics technologies. Management highlighted 11 customers across 2.5D programs and five HDFO customers with 10 active engagements, targeting four product launches in each category during 2026. Its 10-year advanced packaging agreement with TSMC and multi-year NVIDIA partnership strengthen technology collaboration and long-term growth opportunities.

Improving manufacturing efficiency provides another advantage. Gross margin expanded to 16.8% from 12% a year earlier, supported by higher factory utilization. Meanwhile, manufacturing expansions in Arizona and Korea should strengthen its ability to support future AI and high-performance computing demand.

However, substantial capital requirements, semiconductor cyclicality and manufacturing execution risks remain challenges. Amkor expects 2026 capital expenditures of $2.5 billion to $3 billion, while underutilized Arizona capacity could pressure margins during its initial ramp.

Accelerating AI demand, expanding customer programs and strategic partnerships position Amkor to sustain advanced packaging growth, but successful capacity ramps and consistent utilization will be essential to sustaining momentum.

How Are AMKR’s Advanced Packaging Rivals Positioned?Intel Corporation (INTC - Free Report) competes in advanced AI packaging through its Foundry business, offering EMIB silicon bridges, Foveros 3D stacking and EMIB-T technology. Intel operates advanced packaging facilities in New Mexico, supporting high-density chiplet integration for demanding data center workloads. By combining semiconductor fabrication with advanced assembly and testing capabilities, Intel offers an integrated manufacturing alternative that could challenge Amkor's position in complex AI packaging.

GlobalFoundries (GFS - Free Report) is expanding its presence in the advanced packaging ecosystem through silicon interposer manufacturing. In October 2026, GlobalFoundries announced a five-year, $2 billion agreement with TSMC to manufacture silicon interposers for its CoWoS advanced packaging ecosystem. With production expected to ramp in the first half of 2028, GlobalFoundries could strengthen competition for advanced packaging opportunities, although its interposer manufacturing role differs from Amkor's assembly-and-test services.

AMKR’s Share Price Performance, Valuation & EstimatesAMKR’s shares are up 6.5% year to date, underperforming the broader Zacks Computer and Technology sector’s 15.8% growth.

AMKR’s YTD Price Performance
Image Source: Zacks Investment Research

From a valuation standpoint, AMKR trades at a forward 12-month P/E of 15.56X, higher than the industry average of 11.36X. The company carries a Value Score of A.

AMKR’s Valuation
Image Source: Zacks Investment Research

The Zacks Consensus Estimate for 2026 earnings is pegged at $2.60 per share, unchanged over the past 30 days, implying 73.3% year-over-year growth.

Image Source: Zacks Investment Research

AMKR stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

-

Leading institutions will evaluate StarGuide GXi across quantitative imaging, dynamic imaging and emerging theranostic applications Clinical experience from more than 1,000 patient studies was established ahead of the European Association of Nuclear Medicine (EANM) 2026 Annual Meeting in Vienna, Austria Insights will help guide the future evolution of GE HealthCare's digital SPECT/CT platform and inform the next generation of nuclear medicine imaging CHICAGO & VIENNA--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced a global clinical evaluation program spanning three continents and five internationally recognized institutions to assess StarGuide™ GX,i its next-generation digital 4D SPECT/CT system. Participating institutions include Hadassah Medical Center in Israel; Mayo Clinic in the United States; Oncopole Claudius Regaud – Institut Universitaire du Cancer de Toulouse in France; Peking University First Hospital in China; and Rambam Health Care Campus.

Across the program, participating institutions will evaluate image quality, quantitative performance, dynamic imaging and workflow while providing clinical and research feedback to help inform the future evolution of StarGuide GX.

“Nuclear medicine is entering a new era in which imaging is expected to do more than identify disease – it is increasingly being used to quantify biological processes, support treatment decisions and monitor response to therapy,” said Erez Levy, Executive Director, Molecular Imaging, GE HealthCare. “By working across multiple regions and care environments, we aim to generate clinical and research insights that can help inform innovation as imaging, quantitation and workflow needs evolve.”

Expanding quantitative and dynamic imaging capabilities

StarGuide GX uses dual-sided cadmium zinc telluride (dsCZT) detector technology and is designed to support high-sensitivity, high-resolution imaging, quantitative imaging and dynamic acquisitions. Its detector configuration allows the detectors to move close to the patient during imaging, while its patented dual-collimator detector design is intended to eliminate the need for manual external collimator exchanges and streamline imaging workflows.

Additionally, the system is engineered to support radionuclides across a broad energy range and, in research settings, it may also be evaluated for imaging radionuclides associated with emerging alpha-emitter research, including Actinium-225, focused on the potential to expand theranostic applications.ii

“The technological innovations introduced by StarGuide GX are particularly exciting for the future of theranostics,” shared Prof. Frederic Courbon, Head of the Imaging Department, Oncopole Claudius Regaud – Institut Universitaire du Cancer de Toulouse. “The system's ergonomic design and flexibility have the potential to significantly improve workflow while supporting precision in quantitative imaging and high-energy radionuclide applications. Our first experience suggests that StarGuide GX represents a meaningful step forward in enabling advanced theranostic practices.”

StarGuide GX also uses NVIDIA RTX™ accelerated computing to support image reconstruction, and includes a Low-Medium Energy collimator that is designed to provide up to 2.67-times system volume sensitivity.iii

Global collaborations advance nuclear medicine research

Five new, global clinical collaborations will evaluate the platform across diverse care settings:iv

Hadassah Medical Center (Israel): Evaluate advanced quantitative capabilities following the system’s recent field upgrade. Mayo Clinic (United States): Evaluate advanced quantitative and dynamic imaging applications. Oncopole Claudius Regaud – Institut Universitaire du Cancer de Toulouse (France): Assess StarGuide GX, the department's general-purpose SPECT/CT platform, across routine oncology imaging and clinical research. Peking University First Hospital (China): Explore novel tracer research and preclinical applications. Rambam Health Care Campus (Israel): Evaluate StarGuide GX imaging workflows through extensive clinical use across a broad range of nuclear medicine applications and tracers. These new collaborations build on GE HealthCare’s work with University Hospital Essen in Germany, which in June 2026 opened a new state-of-the-art Nuclear Medicine Center featuring the world’s first installation of StarGuide GX SPECT/CT.

To date, these diverse healthcare institutions have scanned more than 1,000 patients.

StarGuide GX received CE Mark in November 2025 and is available for sale in select European Union member states. The system is 510(k) pending with the U.S. FDA and is not currently available for sale in the United States.

For more information about GE HealthCare’s molecular imaging portfolio, visit gehealthcare.com or see the system in the company’s booth at the European Association of Nuclear Medicine’s 2026 Annual Meeting, October 17-21 in Vienna, Austria.

About GE HealthCare Technologies Inc.

GE HealthCare is a leading global healthcare solutions provider of advanced medical technology, pharmaceutical diagnostics, and AI, cloud and software solutions that help clinicians tackle the world’s most complex diseases. Serving patients and providers for 130 years, GE HealthCare is delivering bold innovations designed for the next era of medicine across its Advanced Imaging Solutions, Pharmaceutical Diagnostics and Patient Care Solutions segments to help clinicians deliver more personalized, precise patient care. We are a $20.6 billion business with approximately 54,000 colleagues working to create a world where healthcare has no limits.

GE HealthCare is proud to be among 2026 Fortune World’s Most Admired Companies™.

Follow us on LinkedIn, Facebook, Instagram, or visit our website for our latest news and perspectives.

StarGuide GX is CE marked and 510(k) pending with the U.S. FDA. Not available for sale in the United States. Investigational tracers. Not approved by the U.S. FDA or any other regulatory authority for clinical use. StarGuide GX with Low-Medium collimator has up to a 2.67-times increase in system volume sensitivity compared with NM/CT 870 DR with LEHRS collimator. System volume sensitivity measured per NEMA NU-1 2023, with adaptations for StarGuide GX. The products and applications evaluated may be investigational, may not be commercially available in all markets and may be subject to applicable regulatory requirements. Evaluation activities and timelines vary by institution. More News From GE HealthCare

Back to Newsroom

Asbury Automotive Group (ABG - Free Report) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended September 2026. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.

The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on October 27. On the other hand, if they miss, the stock may move lower.

While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.

Zacks Consensus EstimateThis auto dealership chain is expected to post quarterly earnings of $6.46 per share in its upcoming report, which represents a year-over-year change of -9.9%.

Revenues are expected to be $4.43 billion, down 7.7% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 6.08% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core.

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for Asbury Automotive?For Asbury Automotive, the Most Accurate Estimate is the same as the Zacks Consensus Estimate, suggesting that there are no recent analyst views which differ from what have been considered to derive the consensus estimate. This has resulted in an Earnings ESP of 0%.

On the other hand, the stock currently carries a Zacks Rank of #5.

So, this combination makes it difficult to conclusively predict that Asbury Automotive will beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that Asbury Automotive would post earnings of $6.3 per share when it actually produced earnings of $6.82, delivering a surprise of +8.25%.

Over the last four quarters, the company has beaten consensus EPS estimates two times.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

Asbury Automotive doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.

Should You Invest in Asbury Automotive Group, Inc. (ABG)?

Before you invest in Asbury Automotive Group, Inc. (ABG), want to know the best stocks to buy for the next 30 days? Check out Zacks Investment Research for our free report on the 7 best stocks to buy.

Zacks Investment Research has been committed to providing investors with tools and independent research since 1978. For more than a quarter century, the Zacks Rank stock-rating system has more than doubled the S&P 500 with an average gain of +24.08% per year. (These returns cover a period from January 1, 1988 through May 6, 2024.)

O-I Glass (OI - Free Report) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended September 2026. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.

The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on October 27. On the other hand, if they miss, the stock may move lower.

While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.

Zacks Consensus EstimateThis glass container manufacturer is expected to post quarterly earnings of $0.03 per share in its upcoming report, which represents a year-over-year change of -93.8%.

Revenues are expected to be $1.52 billion, down 8% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 25% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for O-I Glass?For O-I Glass, the Most Accurate Estimate is the same as the Zacks Consensus Estimate, suggesting that there are no recent analyst views which differ from what have been considered to derive the consensus estimate. This has resulted in an Earnings ESP of 0%.

On the other hand, the stock currently carries a Zacks Rank of #3.

So, this combination makes it difficult to conclusively predict that O-I Glass will beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that O-I Glass would post earnings of $0.22 per share when it actually produced earnings of $0.09, delivering a surprise of -59.09%.

Over the last four quarters, the company has beaten consensus EPS estimates two times.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

O-I Glass doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.

LPL Financial Holdings Inc. (LPLA - Free Report) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2026. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.

The earnings report, which is expected to be released on October 27, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.

While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.

Zacks Consensus EstimateThis company is expected to post quarterly earnings of $5.69 per share in its upcoming report, which represents a year-over-year change of +9.4%.

Revenues are expected to be $5.35 billion, up 18.9% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 1.54% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core.

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for LPL Financial?For LPL Financial, the Most Accurate Estimate is the same as the Zacks Consensus Estimate, suggesting that there are no recent analyst views which differ from what have been considered to derive the consensus estimate. This has resulted in an Earnings ESP of 0%.

On the other hand, the stock currently carries a Zacks Rank of #3.

So, this combination makes it difficult to conclusively predict that LPL Financial will beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that LPL Financial would post earnings of $5.39 per share when it actually produced earnings of $5.84, delivering a surprise of +8.35%.

Over the last four quarters, the company has beaten consensus EPS estimates four times.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

LPL Financial doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.

Wall Street expects a year-over-year increase in earnings on higher revenues when Range Resources (RRC - Free Report) reports results for the quarter ended September 2026. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.

The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on October 27. On the other hand, if they miss, the stock may move lower.

While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.

Zacks Consensus EstimateThis independent oil and gas company is expected to post quarterly earnings of $0.70 per share in its upcoming report, which represents a year-over-year change of +22.8%.

Revenues are expected to be $795.99 million, up 10.9% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 8.08% higher over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core.

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for Range Resources?For Range Resources, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -1.11%.

On the other hand, the stock currently carries a Zacks Rank of #3.

So, this combination makes it difficult to conclusively predict that Range Resources will beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that Range Resources would post earnings of $0.56 per share when it actually produced earnings of $0.79, delivering a surprise of +41.07%.

Over the last four quarters, the company has beaten consensus EPS estimates four times.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

Range Resources doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.

Arch Capital Group (ACGL - Free Report) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended September 2026. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.

The earnings report, which is expected to be released on October 27, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.

While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.

Zacks Consensus EstimateThis property and casualty insurer is expected to post quarterly earnings of $2.05 per share in its upcoming report, which represents a year-over-year change of -26%.

Revenues are expected to be $4.46 billion, down 5.5% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 0.48% higher over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core.

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for Arch Capital?For Arch Capital, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +11.70%.

On the other hand, the stock currently carries a Zacks Rank of #3.

So, this combination indicates that Arch Capital will most likely beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that Arch Capital would post earnings of $2.49 per share when it actually produced earnings of $2.56, delivering a surprise of +2.81%.

Over the last four quarters, the company has beaten consensus EPS estimates four times.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

Arch Capital appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

Expected Results of an Industry PlayerAmong the stocks in the Zacks Insurance - Property and Casualty industry, Kinsale Capital Group, Inc. (KNSL - Free Report) , is soon expected to post earnings of $4.95 per share for the quarter ended September 2026. This estimate indicates a year-over-year change of -5%. This quarter's revenue is expected to be $478.84 million, down 3.8% from the year-ago quarter.

The consensus EPS estimate for Kinsale Capital Group has been revised 0.4% lower over the last 30 days to the current level. However, a higher Most Accurate Estimate has resulted in an Earnings ESP of +2.56%.

When combined with a Zacks Rank of #3 (Hold), this Earnings ESP indicates that Kinsale Capital Group will most likely beat the consensus EPS estimate. The company beat consensus EPS estimates in each of the trailing four quarters.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.

Wall Street expects a year-over-year increase in earnings on higher revenues when Seacoast Banking (SBCF - Free Report) reports results for the quarter ended September 2026. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.

The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on October 27. On the other hand, if they miss, the stock may move lower.

While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.

Zacks Consensus EstimateThis holding company for Seacoast National Bank is expected to post quarterly earnings of $0.65 per share in its upcoming report, which represents a year-over-year change of +25%.

Revenues are expected to be $215.65 million, up 36.4% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 0.37% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core.

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for Seacoast Banking?For Seacoast Banking, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -0.38%.

On the other hand, the stock currently carries a Zacks Rank of #3.

So, this combination makes it difficult to conclusively predict that Seacoast Banking will beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that Seacoast Banking would post earnings of $0.6 per share when it actually produced earnings of $0.61, delivering a surprise of +1.67%.

Over the last four quarters, the company has beaten consensus EPS estimates three times.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

Seacoast Banking doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

An Industry Player's Expected ResultsAmong the stocks in the Zacks Banks - Southeast industry, Amerant Bancorp Inc. (AMTB - Free Report) , is soon expected to post earnings of $0.57 per share for the quarter ended September 2026. This estimate indicates a year-over-year change of +46.2%. This quarter's revenue is expected to be $103.25 million, down 7.4% from the year-ago quarter.

Over the last 30 days, the consensus EPS estimate for Amerant Bancorp has been revised 1% down to the current level. Nevertheless, the company now has an Earnings ESP of -5.26%, reflecting a lower Most Accurate Estimate.

This Earnings ESP, combined with its Zacks Rank #4 (Sell), makes it difficult to conclusively predict that Amerant Bancorp will beat the consensus EPS estimate. Over the last four quarters, the company surpassed consensus EPS estimates three times.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.

The market expects Kadant (KAI - Free Report) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2026. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.

The earnings report might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.

While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.

Zacks Consensus EstimateThis equipment supplier for the papermaking and paper recycling industries is expected to post quarterly earnings of $3.00 per share in its upcoming report, which represents a year-over-year change of +15.8%.

Revenues are expected to be $300.97 million, up 10.8% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 3.01% higher over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for Kadant?For Kadant, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -1.50%.

On the other hand, the stock currently carries a Zacks Rank of #3.

So, this combination makes it difficult to conclusively predict that Kadant will beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that Kadant would post earnings of $2.94 per share when it actually produced earnings of $3.42, delivering a surprise of +16.33%.

Over the last four quarters, the company has beaten consensus EPS estimates four times.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

Kadant doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.

Wall Street expects a year-over-year increase in earnings on higher revenues when Hubbell (HUBB - Free Report) reports results for the quarter ended September 2026. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.

The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on October 27. On the other hand, if they miss, the stock may move lower.

While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.

Zacks Consensus EstimateThis electrical products manufacturer is expected to post quarterly earnings of $5.77 per share in its upcoming report, which represents a year-over-year change of +11.6%.

Revenues are expected to be $1.85 billion, up 23.3% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 1.34% higher over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for Hubbell?For Hubbell, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +0.94%.

On the other hand, the stock currently carries a Zacks Rank of #3.

So, this combination indicates that Hubbell will most likely beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that Hubbell would post earnings of $5.31 per share when it actually produced earnings of $5.52, delivering a surprise of +3.95%.

Over the last four quarters, the company has beaten consensus EPS estimates four times.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

Hubbell appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.

Wall Street expects a year-over-year increase in earnings on higher revenues when MSA Safety (MSA - Free Report) reports results for the quarter ended September 2026. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.

The earnings report might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.

While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.

Zacks Consensus EstimateThis maker of safety products is expected to post quarterly earnings of $2.11 per share in its upcoming report, which represents a year-over-year change of +8.8%.

Revenues are expected to be $527.75 million, up 12.7% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 0.67% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core.

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for MSA Safety?For MSA Safety, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -2.99%.

On the other hand, the stock currently carries a Zacks Rank of #3.

So, this combination makes it difficult to conclusively predict that MSA Safety will beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that MSA Safety would post earnings of $2.14 per share when it actually produced earnings of $2.40, delivering a surprise of +12.15%.

Over the last four quarters, the company has beaten consensus EPS estimates four times.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

MSA Safety doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

An Industry Player's Expected ResultsAmong the stocks in the Zacks Security and Safety Services industry, Allegion (ALLE - Free Report) , is soon expected to post earnings of $2.49 per share for the quarter ended September 2026. This estimate indicates a year-over-year change of +8.3%. This quarter's revenue is expected to be $1.13 billion, up 6% from the year-ago quarter.

The consensus EPS estimate for Allegion has been revised 1% higher over the last 30 days to the current level. However, a higher Most Accurate Estimate has resulted in an Earnings ESP of +0.40%.

This Earnings ESP, combined with its Zacks Rank #3 (Hold), suggests that Allegion will most likely beat the consensus EPS estimate. Over the last four quarters, the company surpassed consensus EPS estimates two times.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.

The upcoming report from Hexcel (HXL - Free Report) is expected to reveal quarterly earnings of $0.48 per share, indicating an increase of 29.7% compared to the year-ago period. Analysts forecast revenues of $496.24 million, representing an increase of 8.8% year over year.

Over the past 30 days, the consensus EPS estimate for the quarter has been adjusted upward by 2.2% to its current level. This demonstrates the covering analysts' collective reassessment of their initial projections during this period.

Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.

While it's common for investors to rely on consensus earnings and revenue estimates for assessing how the business may have performed during the quarter, exploring analysts' forecasts for key metrics can yield valuable insights.

That said, let's delve into the average estimates of some Hexcel metrics that Wall Street analysts commonly model and monitor.

The consensus among analysts is that 'Net Sales- Composite Materials' will reach $401.06 million. The estimate indicates a change of +5% from the prior-year quarter.

It is projected by analysts that the 'Net Sales- Engineered products' will reach $101.17 million. The estimate points to a change of +7.2% from the year-ago quarter.

Based on the collective assessment of analysts, 'Net Sales- Commercial Aerospace- Engineered Products' should arrive at $48.17 million. The estimate indicates a year-over-year change of +10.5%.

Analysts predict that the 'Net Sales- Commercial Aerospace- Total' will reach $320.12 million. The estimate suggests a change of +16.8% year over year.

According to the collective judgment of analysts, 'Net Sales- Defense, Space & Other- Total' should come in at $173.21 million. The estimate indicates a change of -4.8% from the prior-year quarter.

Analysts expect 'Net Sales- Defense, Space & Other- Composite Materials' to come in at $138.38 million. The estimate indicates a year-over-year change of +4.4%.

The average prediction of analysts places 'Net Sales- Commercial Aerospace- Composite Materials' at $272.42 million. The estimate suggests a change of +18.1% year over year.

Analysts' assessment points toward 'Net Sales- Defense, Space & Other- Engineered Products' reaching $52.83 million. The estimate indicates a year-over-year change of +6.9%.

The collective assessment of analysts points to an estimated 'Operating income- Composite Materials' of $60.84 million. Compared to the current estimate, the company reported $39.90 million in the same quarter of the previous year.

The combined assessment of analysts suggests that 'Operating income- Engineered Products' will likely reach $13.28 million. The estimate compares to the year-ago value of $13.60 million.

View all Key Company Metrics for Hexcel here>>>

Hexcel shares have witnessed a change of +5.4% in the past month, in contrast to the Zacks S&P 500 composite's +0.7% move. With a Zacks Rank #3 (Hold), HXL is expected closely follow the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .

Key Takeaways QBTS held $546.2M in cash and securities as of June 2026-end, down 33% largely due to Quantum Circuits.
Adjusted EBITDA loss widened to $69.9M in the first half of 2026 as D-Wave increased development spending.
D-Wave's QCaaS subscription revenues grew over 30%, while bookings reached $35.5M in the first half of 2026.

D-Wave Quantum (QBTS - Free Report) retains substantial liquidity to fund product development and commercial expansion despite a decline in cash following its Quantum Circuits acquisition. As of June 30, 2026, cash and marketable securities totaled $546.2 million, down 33% from $819.3 million a year earlier. More than 90% of the decline was linked to the approximately $250 million cash consideration paid for the acquisition.

However, D-Wave continues to increase spending on product development and go-to-market initiatives. Adjusted EBITDA loss widened to $69.9 million in the first half of 2026 from $26.1 million a year earlier. Its liquidity provides flexibility to advance both annealing and gate-model quantum computing technologies.

The company is also expanding its quantum computing-as-a-service (QCaaS) business. First-half subscription revenues rose more than 30% year over year to $3.6 million. Bookings reached $35.5 million, while remaining performance obligations totaled $40.7 million at the end of June, providing visibility into future contracted revenues.

Stockholders' equity totaled $1.08 billion. Overall, D-Wave's liquidity and contracted business provide resources to support its technology roadmap and commercial expansion. However, continued investment and rising operating losses remain important factors in assessing its financial runway.

Peer UpdateIonQ (IONQ - Free Report) ended June 2026 with about $3.0 billion of cash, cash equivalents, restricted cash and investments before the SkyWater closing. After subtracting cash used for the acquisition, cash equivalents and investments were about $2.0 billion. 

IONQ’s remaining performance obligations rose to $485 million as of June 30, 2026, from $470 million as of March 31, 2026, and the company expects about half of the June balance to convert to revenues within the next 12 months. This provides multi-quarter visibility as IonQ funds R&D, manufacturing and go-to-market investment. Operating cash outflow totaled $254.8 million in the first half of 2026, underscoring the importance of maintaining adequate liquidity to support ongoing investments.

Microsoft’s (MSFT - Free Report) heavy infrastructure spending is absorbing a growing share of its operating cash generation. Cash, cash equivalents and short-term investments totaled $76.8 billion as of June 30, 2026, down from $94.6 billion a year earlier. Cash flow from operations rose about 30% year over year to $55.4 billion in fourth-quarter fiscal 2026, but free cash flow fell 23% to $19.6 billion as investment accelerated. 

MSFT expects free cash flow to return to positive growth during fiscal 2027, so execution on that recovery matters as capital expenditures remain elevated. MSFT’s property and equipment, net, increased to $313.1 billion from $205.0 billion a year earlier, expanding the asset base that must earn adequate returns. Long-term debt, including the current portion, amounted to $31.1 billion as of fiscal 2026-end, leaving less financial flexibility if AI infrastructure develops more slowly than expected.

HARTSVILLE, S.C., Oct. 20, 2026 (GLOBE NEWSWIRE) -- The Board of Directors of Sonoco Products Company (“Sonoco” or the “Company”) (NYSE: SON), a mid-cap value global packaging company, has declared a $0.54 per share quarterly common stock dividend. This dividend is payable on December 10, 2026, to shareholders of record as of November 10, 2026.

According to Howard Coker, president and chief executive officer, this is the 407th consecutive quarter dating back to 1925, that the Company has paid dividends to shareholders. Sonoco has increased its annual dividend for 43 consecutive years. Based on the closing price of Sonoco’s common stock on October 19, 2026, the Company dividend provides an approximate 4.3% yield, which is more than double the dividend yield of the S&P 500 Index.

About Sonoco
Founded in 1899, Sonoco (NYSE: SON) is a global leader in value-added, sustainable metal and paper consumer and industrial packaging. Sonoco had net sales of $7.5 billion from continuing operations in 2025 and has approximately 22,000 employees working in 265 operations in 37 countries, serving some of the world’s best-known brands. Guided by our purpose of Better Packaging. Better Life., we strive to foster a culture of innovation, collaboration and excellence to provide solutions that better serve all our stakeholders and support a more sustainable future. A Fortune 500 company, Sonoco was proudly named one of the World’s Most Admired Companies by Fortune in 2026 as well as one of America’s Most Admired and Responsible Companies by Fortune and Newsweek. In 2025, the Company was included on USA TODAY’s list of America’s Climate Leaders. For more information on the Company, visit our website at www.sonoco.com.

Contact: Roger Schrum 
843-339-6018
[email protected]

This press release was published by a CLEAR® Verified individual.

BigBear.ai Holdings, Inc. (BBAI - Free Report) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended September 2026. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.

The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on October 27. On the other hand, if they miss, the stock may move lower.

While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.

Zacks Consensus EstimateThis company is expected to post quarterly loss of $0.06 per share in its upcoming report, which represents a year-over-year change of +14.3%.

Revenues are expected to be $38.94 million, up 17.5% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for BigBear.ai?For BigBear.ai, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -9.09%.

On the other hand, the stock currently carries a Zacks Rank of #3.

So, this combination makes it difficult to conclusively predict that BigBear.ai will beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that BigBear.ai would post a loss of$0.05 per share when it actually produced a loss of -$0.04, delivering a surprise of +20.00%.

Over the last four quarters, the company has beaten consensus EPS estimates two times.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

BigBear.ai doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.

Despite Figma co-founder Dylan Field’s concerns about MCP (model context protocol), which standardizes how AI agents connect to external data sources and tools, the company is expanding its support for the open source standard.

At the design company’s first Config conference held in India, the company announced 20 new model context protocol (MCP) partners, including Amp, ClickUp, Dia, Junie by JetBrains, Linear, Meta Muse, Mistral, Notion, OpenCode, and Sarvam Agents.

Field has expressed his misgivings about MCP before. Days before this announcement, one of MCP’s co-creators complained about Figma not supporting the open-source tool Pi. As part of his response, Field made a comment about Anthropic not making its various resources available via MCP.

“I find it interesting that Anthropic (creators of MCP standard) do not expose artifacts / other cloud resources created via MCP,” he wrote on X. “The debate is framed as open vs closed. Everyone always prefers open… obviously. And meanwhile issues of asymmetric context sharing are ignored.”

(Field later added that Figma plans support Pi.)

Can you help me understand why you don't make various Anthropic resources available via MCP? Maybe I'm missing something.

— Dylan Field (@zoink) September 30, 2026 At a media briefing, I asked Field about this debate. The co-founder explained that while Figma wants to be open, he doesn’t think MCP is a perfect protocol.

“I’m really excited about what we’re doing in terms of opening up our ecosystem. I also think that MCP is not a perfect protocol. And I think that it is something that has tons of room for improvement,” the co-founder responded. “It is advantaged more to frontier labs. Also, I understand everyone online who just wants a protocol that they can use when they want to use their Figma data, and I want them to use it, too.”

Figma’s CEO said that the reason the company doesn’t want to be fully open is that the more data the company exposes through MCP, the higher the chance of abuse.

He also clarified that while most users don’t intend to use MCP or Figma data in a malicious way, the company still has to think about those potential risks.

When you purchase through links in our articles, we may earn a small commission. This doesn’t affect our editorial independence.

Ivan covers global consumer tech developments at TechCrunch. He is based out of India and has previously worked at publications including Huffington Post and The Next Web.

You can contact or verify outreach from Ivan by emailing [email protected] or via encrypted message at ivan.42 on Signal.

Key Takeaways SL Green signed 129 Manhattan office leases totaling 1.76 million square feet through Sept. 14, 2026.Occupancy reached 94.7% in June 2026, while replacement leases fetched rents 15.8% above prior rates.SL Green plans to use $216 million in expected sale proceeds to repay debt amid rising interest expenses.
SL Green (SLG - Free Report) is well-positioned to capitalize on rising demand for premium office properties in Manhattan. Strong leasing activity, improving occupancy and higher rental rates support its growth prospects. Its diversified tenant base and strategic capital recycling initiatives are expected to strengthen portfolio quality and financial flexibility.

However, elevated debt, refinancing requirements and geographic concentration remain concerns. Competition from office REITs like Vornado Realty Trust (VNO - Free Report) and BXP, Inc. (BXP - Free Report) also adds pressure.

SL Green's recent leasing momentum highlights sustained demand for its premium office properties. From the beginning of 2026 through Sept. 14, the company signed 129 Manhattan office leases aggregating 1.76 million square feet. Replacement leases were priced 15.8% above previous fully escalated rents.

What's Aiding SL Green?Demand for high-quality, amenity-rich office properties continues to support SL Green's leasing activities. The company benefits from its prime Manhattan locations and strong tenant relationships. Manhattan same-store leased occupancy rose to 94.7% as of June 30, 2026, from 93% at year-end 2025. Same-store cash NOI increased 4.3% year over year in the second quarter of 2026, excluding lease termination income. Management expects leased occupancy to reach 95% by year-end 2026. Similar to Vornado Realty Trust and BXP, SL Green is positioned to benefit from tenants' preference for modern, well-located office properties.

SL Green maintains a diversified tenant portfolio across industries, reducing its reliance on individual tenants. Excluding Paramount Global, no tenant accounted for more than 5% of annualized cash rent as of June 30, 2026, including joint venture exposure. Its long-term lease arrangements provide revenue visibility and support relatively stable rental cash flows. During the first half of 2026, Manhattan office leases carried an average term of 8.5 years.

SL Green continues to pursue acquisitions, dispositions and joint ventures to enhance portfolio quality. In September 2026, SL Green agreed to sell 110 Greene Street in SoHo for $226 million, with approximately $216 million in expected net cash proceeds earmarked for unsecured corporate debt repayment. Such initiatives should provide financial flexibility and support long-term growth.

What's Hurting SL Green?SL Green operates in a competitive office real estate market, facing pressure from other property owners and developers. Established office REITs, including Vornado Realty Trust and BXP, compete for tenants seeking premium office space. Such competition may require SL Green to provide attractive leasing incentives, affecting net effective rental growth. During the first half of 2026, its Manhattan office leases carried average concessions of 8.8 months of free rent and tenant improvement allowances of $91.89 per rentable square foot.

SL Green's portfolio remains heavily concentrated in Manhattan, making its operating performance sensitive to New York City's economic conditions. As of June 30, 2026, the company held interests in 54 buildings totaling 30.6 million square feet, with most ownership exposure tied to Manhattan commercial assets. A slowdown in local office demand could adversely affect occupancy and rental revenues.

Elevated leverage and interest expenses remain major concerns. SL Green's consolidated debt totaled $4.55 billion as of June 30, 2026. Variable-rate debt increased to 20.4% from 9.1% at year-end 2025. Interest expense, net of interest income, rose to $54 million in the second quarter of 2026 from $45.3 million a year earlier. This increases the company's vulnerability to refinancing challenges and unfavorable interest-rate movements.

Note: Anything related to earnings presented in this write-up represents funds from operations (FFO), a widely used metric to gauge the performance of REITs.

Wall Street expects a year-over-year increase in earnings on higher revenues when Modine (MOD - Free Report) reports results for the quarter ended September 2026. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.

The stock might move higher if these key numbers top expectations in the upcoming earnings report. On the other hand, if they miss, the stock may move lower.

While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.

Zacks Consensus EstimateThis heating and cooling products maker is expected to post quarterly earnings of $1.47 per share in its upcoming report, which represents a year-over-year change of +38.7%.

Revenues are expected to be $964.62 million, up 30.6% from the year-ago quarter.

Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 13.77% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.

Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.

Price, Consensus and EPS Surprise

Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).

The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.

Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.

A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.

Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).

How Have the Numbers Shaped Up for Modine?For Modine, the Most Accurate Estimate is the same as the Zacks Consensus Estimate, suggesting that there are no recent analyst views which differ from what have been considered to derive the consensus estimate. This has resulted in an Earnings ESP of 0%.

On the other hand, the stock currently carries a Zacks Rank of #5.

So, this combination makes it difficult to conclusively predict that Modine will beat the consensus EPS estimate.

Does Earnings Surprise History Hold Any Clue?While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.

For the last reported quarter, it was expected that Modine would post earnings of $1.27 per share when it actually produced earnings of $1.53, delivering a surprise of +20.47%.

Over the last four quarters, the company has beaten consensus EPS estimates four times.

Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.

That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.

Modine doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.

Expected Results of an Industry PlayerAnother stock from the Zacks Automotive - Original Equipment industry, Gentherm (THRM - Free Report) , is soon expected to post earnings of $0.66 per share for the quarter ended September 2026. This estimate indicates a year-over-year change of -9.6%. Revenues for the quarter are expected to be $404.4 million, up 4.5% from the year-ago quarter.

Over the last 30 days, the consensus EPS estimate for Gentherm has been revised 2.3% down to the current level. Nevertheless, the company now has an Earnings ESP of +0.45%, reflecting a higher Most Accurate Estimate.

This Earnings ESP, combined with its Zacks Rank #4 (Sell), makes it difficult to conclusively predict that Gentherm will beat the consensus EPS estimate. Over the last four quarters, the company surpassed consensus EPS estimates three times.

Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.

SpaceX (SPCX -1.18%) has gone on a wild ride since its IPO on June 12. The aerospace and AI company went public at $135 per share, closed at a record high of $211.39 on June 16, but now trades at $145. Let's see why it fizzled out -- and if it's worth buying below its IPO price.

Why did SpaceX's stock initially soar?
SpaceX initially attracted a lot of attention because Elon Musk founded it, it was growing rapidly, and it had an early mover advantage in the space logistics, satellite, and AI markets. It capitalized on that hype by offering less than 5% of its shares in its IPO. It allocated about a fifth of those shares to retail investors rather than institutional investors.

Image source: Getty Images.

SpaceX's revenue rose 33% to $18.67 billion in 2025, but Musk declared it could generate $1 trillion in revenue by 2030. That optimistic outlook -- which would require SpaceX to grow its top line at an unprecedented 121.7% CAGR from 2025 to 2030 -- attracted a stampede of bulls.

Why did SpaceX's stock give up most of those gains?
At its peak, SpaceX's market cap reached $2.64 trillion, or 58 times the $45.3 billion in revenue analysts expected it to generate in 2026. Some bulls might argue that its breakneck growth rates justify that premium valuation. Still, rising interest rates and Treasury yields drove investors toward more conservative investments over the following four months.

SPCX Space Exploration Technologies$146.22-$1.74 (-1.18%)

NASDAQ · As of 11:34 AM ET 10/20/26

The tougher macro headwinds also made it tough to overlook SpaceX's massive losses. SpaceX's only profitable business division is Starlink, but the losses at its space and AI businesses are wiping out those profits.

In the first half of 2026, Starlink generated an operating profit of $2.84 billion, which was erased by the space segment's operating loss of $1.20 billion and the AI segment's operating loss of $3.73 billion. Those losses will widen as SpaceX ramps up production of Starship, the largest rocket ever built, and expands its AI business (which includes X, Grok, and Cursor).

Many investors also fretted over SpaceX's lockup expirations, which started in early August and will continue through the end of the year. With so much of its future growth already priced into its stock, it would be tempting for SpaceX's early investors and insiders to take some profits.

What would I do if SpaceX's shares drop below $135?
SpaceX will post its third-quarter earnings after the market closes on Oct. 20. Analysts expect its revenue to rise 65% sequentially -- with its AI revenue climbing 153%, Starlink revenue growing 15%, and its space revenue increasing 52%.

That quarter-over-quarter growth should be driven by the expansion of its AI infrastructure (which secured major contracts with Anthropic and other AI companies), the expansion of Starlink's satellite constellation and subscriber base, and its ongoing rocket launches.

Even if SpaceX matches or beats those estimates, it must grow its backlog -- which reached $47.5 billion at the end of June -- to impress the bulls. It should also lay out clearer plans for monetizing its AI business and kick-starting Starlink's direct-to-cell evolution (which was accelerated by its recent acquisition of 800 MHz spectrum from Grain Management).

At $145, SpaceX still has a market cap of $2.0 trillion, or 45 times this year's sales. If it were to revisit its IPO price, it would be worth about $1.8 trillion, or 40 times this year's sales. The bulls will claim that's a reasonable price for a company that could potentially generate $1 trillion in revenue by 2030, but the bears will argue that it will struggle to reach that ambitious goal.

I personally wouldn't touch SpaceX if it dips slightly below its IPO price, because it could trigger panic selling rather than contrarian buying in this volatile market. But if it sinks much lower, I'd consider nibbling on it as a long-term, speculative play in the space, satellite, and AI markets.

watch now

Among Jim Cramer's many famous phrases, his one about Apple often stands out: Own it. Don't trade it.

The saying speaks to the company's enduring ability to overcome any obstacle, whether it's concerns about new products or worries about the global economy. The tech giant recently topped $5 trillion for the first time and is closing in on Nvidia as the world's most valuable company. More gains could be ahead. 

Apple recently described the demand for the iPhone Duo, the long awaited foldable iPhone as "nothing short of extraordinary" after pre-orders opened last Friday. The demand was so great, that estimated delivery times pushed back to late January (so much for a stocking stuffer) within minutes of orders being accepted. Combine this with Homeview, the company's new smart hub, new MacBook Pro models and iPads with OLED displays and the Mac studio and associated chips released several weeks ago and the hardware landscape for the most successful consumer electronics company in history is starting to compete with the AI trade for investors' attention. The only problem is that the company already has a lot of good news baked into its valuation.

Compounding this hardware momentum is the software catalyst. The deep integration of Apple Intelligence, including upgraded Siri AI and Visual Intelligence, means that Apple is becoming part of the AI story, with the benefit that, on a relative basis, they haven't had the enormous Capex that is concerning those investors who are concerned that the AI trade is getting frothy as many companies use all their organic cash flow (Amazon, Alphabet) or substantially more than their organic cash flow (Oracle). Apple's anticipated revenues for FY2027 exceeds $500 billion. Expected EBITDA exceeds $180 billion, but the company's capex is paltry relative to the other megacaps at only $13.5 billion in Capex. Result? $156 billion in anticipated free cash flow, and the company reported ~$62 billion in net cash when they reported results for the quarter ended June 27th.

Apple, YTD

The primary headwind for AAPL is valuation. With a $5 trillion market capitalization, Apple is contending with the law of large numbers. Moving the needle at this scale requires monumental revenue beats that are increasingly difficult to engineer. This is particularly true as the stock is already priced quite richly. AAPL's trading at nearly 36 FY2027 EPS estimates of 9.59 well above the long-term average multiple. Apple options are priced above average too, and that may be the good news, because elevated short term premium can help finance the purchase of longer dated optionality. With Apple supported by an extraordinary string of recent product releases and massive free cash flow, but possibly suppressed by high valuations, this could be an excellent opportunity for a call spread risk reversal.

The tradeThe Long Leg: February 360 calls The Short Legs: Sell December 310 puts and the December 375 callsSelling the shorter dated December 310-puts and December 375 calls offsets the cost of buying the longer dated February calls. Ideally, you want Apple shares to stay between the two, short strikes by December expiration and above $360 by February expiration. One note of caution. By selling that downside put will tie up some margin, you could be on the hook to buy the stock at the put's strike by expiration.

If AAPL chops sideways as it digests its valuation, the short strangle expires worthless, lowering the cost basis of your long.

Disclosures: Tidal owns/holds all the securities mentioned in the article.

All opinions expressed by CNBC Pro contributors are solely their opinions and do not reflect the opinions of CNBC, or its parent company or affiliates, and may have been previously disseminated by them on television, radio, internet or another medium. This content is provided as part of our editorial output for informational purposes only and does not constitute financial, investment, tax or legal advice or a recommendation to buy any security or other financial asset. The content is general in nature and does not reflect any individual's unique personal circumstances. The above content might not be suitable for your particular circumstances. Before making any financial decisions, you should strongly consider seeking advice from your own financial or investment advisor.

THIS CONTENT IS PROVIDED FOR INFORMATIONAL PURPOSES ONLY AND DOES NOT CONSTITUTE FINANCIAL, INVESTMENT, TAX OR LEGAL ADVICE OR A RECOMMENDATION TO BUY ANY SECURITY OR OTHER FINANCIAL ASSET. THE CONTENT IS GENERAL IN NATURE AND DOES NOT REFLECT ANY INDIVIDUAL'S UNIQUE PERSONAL CIRCUMSTANCES. THE ABOVE CONTENT MIGHT NOT BE SUITABLE FOR YOUR PARTICULAR CIRCUMSTANCES. BEFORE MAKING ANY FINANCIAL DECISIONS, YOU SHOULD STRONGLY CONSIDER SEEKING ADVICE FROM YOUR OWN FINANCIAL OR INVESTMENT ADVISOR.

Click here for the full disclaimer.

Tesla's proxy filing attached a staggering number to Elon Musk's 2025 pay, but whether shareholders actually lose anything depends on conditions few companies have ever met before.

Tesla (NASDAQ:TSLA | TSLA Price Prediction) filed its definitive proxy at 6:15 a.m. ET on Monday, October 19, 2026, reports Elon Musk’s 2025 compensation at $158,359,009,867, all of it in stock awards. Salary, bonus, option awards, and other pay are all zero, because Musk has never accepted a salary and Tesla has no cash bonus program for named executives.

That total is an accounting value measured at grant date under the standard stock-compensation rule, though Musk has received no cash and no vested stock from it.

Tesla shares rose 3.76% that day to close at $368.06, leaving it with a market cap of $1.45 trillion. The stock is still down 18.16% for the year, and third-quarter results are expected after the close on Wednesday, October 21.

For owners, the headline number mostly leaves what they own unchanged, although the vote and the earnings report both deserve attention.

The 2025 CEO Performance Award accounts for $132,298,849,867, valued at the maximum assuming every condition is met. It covers about 423.7 million shares of performance-based restricted stock.

The rest is a 2025 CEO Interim Award valued at $26,060,160,000, which was fully forfeited in April 2026. The performance award had not been earned or vested as of the proxy.

How Musk Would Actually Earn the Shares The award is split into 12 tranches. Both milestones must be met. Each pays out only when a market-cap milestone and an operational milestone are both met, and earned shares must be held for five years, subject to limited exceptions.

The operational targets reward businesses the proxy highlights. These include 46.7 gigawatt-hours of 2025 storage installations, up 48.7%, plus Cybercab production at Gigafactory Texas, Robotaxi expansion, the Tesla Semi and Optimus lines.

The share count equals roughly 10.7% of Tesla’s 3,949,547,000 shares outstanding. Shareholders give up that stake only if Tesla becomes a far larger company, which many owners are likely to accept.

What Shareholders Can Change on December 3 The annual meeting is Thursday, December 3, 2026, at 3:00 p.m. Central Time. Shareholders vote on three items. These are re-electing Musk, board chair Robyn Denholm, and JB Straubel; a say-on-pay vote; and approving PwC, with the board recommending approval of all three items.

The pay vote is advisory and cannot undo the award, and the chair managing it is herself a candidate. Last year’s say-on-pay drew approximately 78.2% support, while a proposal to drop supermajority voting failed at approximately 39.4% of outstanding shares.

Why the Earnings Report Matters More In the second quarter, operating expenses rose 47% to $4.35 billion, partly from stock compensation tied to this award. Operating margin fell to 1.4%, and non-GAAP EPS of $0.33 missed the $0.5367 estimate. Key-person risk also remains, because Musk runs SpaceX too and recently promised to give away SpaceX shares.

What Long-Term Tesla Owners Need to Weigh Before Earnings The award matters most to owners with a horizon matching Musk’s five-year holding rule, because the accounting figure costs shareholders nothing unless Tesla’s value grows.

Valuation is the larger risk at a P/E of 383x. ARK’s $4,400 long-term target shows how far bullish assumptions stretch.

The test comes on October 21. If operating margin fails to improve on the second quarter’s 1.4%, the bullish case weakens, and the long-term thesis becomes harder to defend.

Contact [email protected] for any questions or corrections.

The artificial intelligence (AI) revolution has produced two of the fastest-growing start-ups in history. OpenAI burst onto the scene in late 2022 when it launched ChatGPT, introducing consumers around the world to generative AI. Meanwhile, Anthropic has emerged as a formidable competitor with its Claude models.

Both companies' growth has been extraordinary. Following a $122 billion funding round in March, OpenAI reached a valuation of $852 billion, while Anthropic was valued at $965 billion after its Series H round in May. Naturally, AI investors are eager to know when they can buy shares.

Anthropic confidentially filed for an initial public offering (IPO) in June and could make its public debut as soon as next month. OpenAI has also explored going public, although its timing remains uncertain.

Here's an interesting alternative: Rather than waiting for either company to go public at a valuation approaching the trillion-dollar milestone, investors can buy Alphabet (GOOGL -0.76%) (GOOG -0.74%) instead. Alphabet stands to benefit regardless of which AI developer ultimately wins. Read on to learn why.

Image source: Getty Images.

Google Cloud already benefits from OpenAI and Anthropic
One of Alphabet's quiet advantages is that it doesn't need its Gemini AI models to beat ChatGPT or Claude. That reason is Google Cloud provides compute infrastructure to its competitors. In May 2025, OpenAI agreed to use Google Cloud's capacity to train and deploy its AI models.

This relationship is particularly interesting because up to that point, OpenAI was primarily tied to Microsoft Azure. Adding Google provided OpenAI with an alternative source of AI compute while giving Alphabet a hyperscaler customer whose infrastructure requirements are enormous.

Anthropic's relationship with Google runs even deeper. In October 2025, Anthropic announced its use of Google's custom silicon, called Tensor Processing Units (TPUs). In April, this relationship was expanded to include multiple gigawatts of TPU capacity expected to come online in 2027.

These arrangements create an attractive business model for Alphabet because the company can develop AI products for consumers while simultaneously supplying infrastructure that competing enterprises need.

The strategy is already producing impressive results. During the second quarter, Google Cloud revenue surged 82% year over year to $24.8 billion. While not all of that growth came from OpenAI and Anthropic, their expanding infrastructure commitments underscore why Google Cloud should remain a major beneficiary of the AI boom.

GOOGL Alphabet$341.57-$2.61 (-0.76%)

NASDAQ · As of 11:33 AM ET 10/20/26

Alphabet is sitting on a generational multibagger
Alphabet isn't just an infrastructure partner to Anthropic. It's also one of the company's largest investors. Google initially invested in Anthropic in 2023. But by early 2026, Alphabet had invested roughly $3 billion in Anthropic and owned an estimated 14% equity stake. In April, Google announced plans to invest up to another $40 billion. The deal was structured to include an initial $10 billion commitment, with an additional $30 billion contingent on Anthropic meeting certain performance milestones.

Why is Google investing so heavily in a company whose generative models compete directly with Gemini?

The answer is simple: Alphabet is positioned to benefit from Anthropic's success in multiple ways. First, its equity investment will appreciate as Anthropic's valuation increases. Additionally, Anthropic is a major customer for Google's cloud infrastructure and custom AI chips. Third, Google's tie-up with Anthropic gives it exposure to an alternative AI ecosystem, reducing its dependence on Gemini emerging as the industry's go-to model.

This is an unusually versatile position to be in. If Anthropic goes public at its reported $2 trillion valuation, a hypothetical 14% stake would be worth $280 billion. This shows how Alphabet can participate in one of the largest IPOs in history without investors needing to lift a finger and buy Anthropic stock directly.

Alphabet is less speculative than an IPO stock
OpenAI's valuation of $852 billion represents approximately 17 times its reported $50 billion annualized revenue run rate. Meanwhile, Anthropic's $965 billion valuation represents 14 times its Q3 annualized revenue run rate of $67.2 billion. At a $2 trillion IPO valuation, Anthropic would trade at nearly 30 times its current revenue run rate.

These are enormous premiums, especially considering the capital expenditures required to develop advanced AI. Moreover, OpenAI remains unprofitable while Anthropic recently reported a small profit on an adjusted operating basis.

Alphabet offers a much different financial profile. During Q2, the company generated $120 billion in revenue and roughly $40.8 billion in operating income. Alphabet stock trades around a 23 times forward price-to-earnings (P/E) ratio -- a relatively reasonable valuation considering its established and highly profitable advertising and cloud businesses.

While OpenAI and Anthropic could become respected public companies, their anticipated valuations already reflect high expectations. Alphabet offers investors exposure to both AI developers through Google Cloud, an existing equity stake in Anthropic, and its own growing AI ecosystem. Combined with its AI-driven revenue and robust profitability, I see Alphabet as the more compelling AI stock to buy and hold ahead of these anticipated mega-IPOs.

Amazon reports Q3 earnings on Oct. 29, and history says the stock pops. But the earnings beat is the least interesting part of the investment case right now.

I keep following Amazon (NASDAQ:AMZN | AMZN Price Prediction), and with third-quarter results due Oct. 29, the stock is back in focus. Amazon beat Q3 EPS estimates in 2023, 2024, and 2025, and the stock rose 6.83%, 6.19%, and 9.58% on those earnings days. I count that run as a bonus. My real reason sits inside AWS.

AWS Is Reaccelerating, and I Want to Own That Curve
AWS growth went from 20% in Q3 2025 to 24%, then 28%, then 37% in Q2 2026. That quarter delivered $42.23 billion in revenue at a 39.4% operating margin. The backlog stands at $496 billion, growing triple digits. The AI and chips businesses each run above $25 billion annually. Management says AWS could “very possibly be a trillion dollar annual revenue business for us in time.” That compounding engine supports the long-term investment case.

Three Data Points Behind the Amazon Thesis
First, growth is broadening. Q2 revenue hit $200.61 billion, up 19.62%, while operating income rose 43.24% to $27.46 billion. Advertising alone brought in $19.81 billion, up 26%.

Second, its financial position can support the expansion. The debt-to-equity ratio sits at 0.37, interest coverage at 35.17, and cash at $78.21 billion.

Third, the long record rewards patience. Shares gained 540.91% over ten years. Amazon pays no dividend, so reinvested profits do the compounding.

How Amazon Stacks Up Against Microsoft and Alphabet
Microsoft (NASDAQ:MSFT) trades at a lower P/E of 30 against Amazon’s 36. Its latest-quarter operating income grew 18.3%, while Amazon’s grew 43.24%. Amazon’s premium reflects faster profit growth.

Alphabet (NASDAQ:GOOGL) looks cheap at 15 times earnings. To fund its AI buildout, though, it raised roughly $70 billion in equity and debt, suspended buybacks, and lifted long-term debt from $46.5 billion to $98.2 billion. I prefer Amazon’s net debt to EBITDA of 0.45 and no share issuance on that scale.

Risk That Could Actually Hurt Me
Free cash flow turned negative at -$7.6 billion on a trailing basis, and Amazon plans about $200 billion in 2026 capex (all of which has to be powered, cooled, and connected by somebody, which is the whole point of our free report on seven suppliers behind the AI buildout). The P/FCF ratio of 367.88 shows it. Reported earnings also include a $53.4 billion Anthropic gain; adjusted EPS came in at $1.88 versus a $1.83 estimate. Jassy admits Amazon will “encounter free cash flow headwinds until these data centers come online.”

I accept that because servers break even in a little less than three years, last five to six years, and most AI capacity is contracted for at least five-year terms. Most of 2027 capacity is already reserved.

Why AWS Momentum Matters Into Earnings
Jassy notes 85% of global IT spending still sits on-premises. Q3 guidance calls for operating income of $22.5 billion to $26.5 billion versus $17.4 billion a year ago. Oct. 29 will show whether AWS keeps compounding.

Contact [email protected] for any questions or corrections.